274 related articles for article (PubMed ID: 24126682)
21. Boceprevir and telaprevir in the management of hepatitis C virus-infected patients.
Butt AA; Kanwal F
Clin Infect Dis; 2012 Jan; 54(1):96-104. PubMed ID: 22156853
[TBL] [Abstract][Full Text] [Related]
22. [Antiviral treatment of chronic hepatitis C].
Berger A
Med Monatsschr Pharm; 2012 Feb; 35(2):55-60. PubMed ID: 22400430
[TBL] [Abstract][Full Text] [Related]
23. Drugs in development for chronic hepatitis C: a promising future.
Pockros PJ
Expert Opin Biol Ther; 2011 Dec; 11(12):1611-22. PubMed ID: 21995412
[TBL] [Abstract][Full Text] [Related]
24. Hepatitis C virus-RNA clearance in HIV-coinfected patients with chronic hepatitis C treated with pegylated interferon plus ribavirin.
Soriano V; Núñez M; Camino N; Maida I; Barreiro P; Romero M; Martin-Carbonero L; Garcia-Samaniego J; González-Lahoz J
Antivir Ther; 2004 Aug; 9(4):505-9. PubMed ID: 15456081
[TBL] [Abstract][Full Text] [Related]
25. Treatment of chronic hepatitis C: current and future.
Pawlotsky JM
Curr Top Microbiol Immunol; 2013; 369():321-42. PubMed ID: 23463207
[TBL] [Abstract][Full Text] [Related]
26. Current status of treatment for chronic hepatitis C virus infection.
Talwani R; Gilliam BL; Rizza SA; Nehra V; Temesgen Z
Drugs Today (Barc); 2012 Mar; 48(3):219-31. PubMed ID: 22462041
[TBL] [Abstract][Full Text] [Related]
27. Hepatitis C virus markers in infection by hepatitis C virus: In the era of directly acting antivirals.
Coppola N; Pisaturo M; Zampino R; Macera M; Sagnelli C; Sagnelli E
World J Gastroenterol; 2015 Oct; 21(38):10749-59. PubMed ID: 26478667
[TBL] [Abstract][Full Text] [Related]
28. [New direct-acting antiviral agents for the treatment of chronic hepatitis C in 2014].
Cornberg M; Höner zu Siederdissen C; Maasoumy B; Manns MP
Internist (Berl); 2014 Apr; 55(4):390-400. PubMed ID: 24652513
[TBL] [Abstract][Full Text] [Related]
29. New hepatitis C virus (HCV) drugs and the hope for a cure: concepts in anti-HCV drug development.
Pawlotsky JM
Semin Liver Dis; 2014 Feb; 34(1):22-9. PubMed ID: 24782255
[TBL] [Abstract][Full Text] [Related]
30. Targets for antiviral therapy of hepatitis C.
Rupp D; Bartenschlager R
Semin Liver Dis; 2014 Feb; 34(1):9-21. PubMed ID: 24782254
[TBL] [Abstract][Full Text] [Related]
31. All Oral Interferon-free Direct-acting Antivirals as Combination Therapies to Cure Hepatitis C.
Shahid I; Ibrahim MM
Curr Mol Med; 2018; 18(7):409-435. PubMed ID: 30608042
[TBL] [Abstract][Full Text] [Related]
32. TMC435 for the treatment of chronic hepatitis C.
Tanwar S; Trembling PM; Dusheiko GM
Expert Opin Investig Drugs; 2012 Aug; 21(8):1193-209. PubMed ID: 22616626
[TBL] [Abstract][Full Text] [Related]
33. [Progress in Examination and Treatment of Hepatitis C Virus].
Suda G; Sakamoto N
Rinsho Byori; 2015 Jun; 63(6):762-7. PubMed ID: 26548242
[TBL] [Abstract][Full Text] [Related]
34. Containing "The Great Houdini" of viruses: combining direct acting antivirals with the host immune response for the treatment of chronic hepatitis C.
Ahlén G; Frelin L; Brenndörfer ED; Brass A; Weiland O; Chen M; Sällberg M
Drug Resist Updat; 2013; 16(3-5):60-7. PubMed ID: 23911647
[TBL] [Abstract][Full Text] [Related]
35. The role of interferon in the new era of hepatitis C treatments.
Parekh PJ; Shiffman ML
Expert Rev Gastroenterol Hepatol; 2014 Aug; 8(6):649-56. PubMed ID: 24758387
[TBL] [Abstract][Full Text] [Related]
36. Hepatitis C therapy: Looking toward interferon-sparing regimens.
Au TH; Destache CJ; Vivekanandan R
J Am Pharm Assoc (2003); 2015; 55(2):e72-84; quiz e85-6. PubMed ID: 25658389
[TBL] [Abstract][Full Text] [Related]
37. [Advances in drug development for hepatitis C].
Suzuki T; Nakashima K; Chida T; Ito M
Uirusu; 2015; 65(2):239-244. PubMed ID: 27760922
[TBL] [Abstract][Full Text] [Related]
38. Genotype 3-hepatitis C virus' last line of defense.
Zarębska-Michaluk D
World J Gastroenterol; 2021 Mar; 27(11):1006-1021. PubMed ID: 33776369
[TBL] [Abstract][Full Text] [Related]
39. [Future prospects for hepatitis C treatment: without interferon and ribavirin?].
Lens S; Alfaro I
Gastroenterol Hepatol; 2014 May; 37(5):311-21. PubMed ID: 24679376
[TBL] [Abstract][Full Text] [Related]
40. Hepatitis C virus infection and immunomodulatory therapies.
Forde KA; Reddy KR
Clin Liver Dis; 2009 Aug; 13(3):391-401. PubMed ID: 19628156
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
